Literature DB >> 19191765

Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs.

L M Kucirka1, R Namuyinga, C Hanrahan, R A Montgomery, D L Segev.   

Abstract

A new United Network for Organ Sharing (UNOS) policy mandates special informed consent (SIC) before transplanting organs from donors classified by the Public Health Service/Center for Disease Control (PHS/CDC) as high-risk donors (HRDs); however, concerns remain that this policy may cause suboptimal organ utilization. Currently, consent and disclosure policy is determined by individual centers or surgeons; as such, little is known about current practices. The goals of this study were to quantify consent and disclosure practices for HRDs in the United States, identify factors associated with SIC use and analyze associations between SIC use and HRD organ utilization. We surveyed 422 transplant surgeons about their use of HRD organs and their associated consent and disclosure practices. In total, 52.7% of surgeons use SIC, but there is a high variation in use within centers, between centers and by donor behavior. A defined HRD policy at a transplant center is strongly associated with SIC use at that center (OR = 4.68, p < 0.001 by multivariate hierarchical logistic regression). SIC use is associated with higher utilization of HRD livers (OR 3.37), and a trend toward higher utilization of HRD kidneys (OR 1.74) and pancreata (OR 1.28). We believe our findings support a formalized national policy and suggest that this policy will not result in decreased utilization.

Entities:  

Mesh:

Year:  2008        PMID: 19191765     DOI: 10.1111/j.1600-6143.2008.02523.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  18 in total

1.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

2.  Treating patients with colon cancer liver metastasis: a nationwide analysis of therapeutic decision making.

Authors:  Hari Nathan; John F Bridges; David P Cosgrove; Luis A Diaz; Daniel A Laheru; Joseph M Herman; Richard D Schulick; Barish H Edil; Christopher L Wolfgang; Michael A Choti; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2012-08-09       Impact factor: 5.344

3.  Understanding surgical decision making in early hepatocellular carcinoma.

Authors:  Hari Nathan; John F P Bridges; Richard D Schulick; Andrew M Cameron; Kenzo Hirose; Barish H Edil; Christopher L Wolfgang; Dorry L Segev; Michael A Choti; Timothy M Pawlik
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

Review 4.  When Theory Becomes Reality: Navigating the Ethics of Transplanting Hepatitis C Virus-Positive Livers Into Negative Recipients.

Authors:  Thomas Couri; Andrew Aronsohn
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-11-06

5.  Implications of declining donor offers with increased risk of disease transmission on waiting list survival in lung transplantation.

Authors:  Morgan L Cox; Michael S Mulvihill; Ashley Y Choi; Muath Bishawi; Asishana A Osho; John C Haney; Mani Daneshmand; Jacob A Klapper; Cameron R Wolfe; Matthew Hartwig
Journal:  J Heart Lung Transplant       Date:  2018-12-21       Impact factor: 10.247

Review 6.  Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis.

Authors:  L M Kucirka; H Sarathy; P Govindan; J H Wolf; T A Ellison; L J Hart; R A Montgomery; R L Ros; D L Segev
Journal:  Am J Transplant       Date:  2011-03-02       Impact factor: 8.086

7.  Risk factors for multidrug-resistant organisms among deceased organ donors.

Authors:  Judith A Anesi; Emily A Blumberg; Jennifer H Han; Dong H Lee; Heather Clauss; Antonette Climaco; Richard Hasz; Esther Molnar; Darcy Alimenti; Sharon West; Warren B Bilker; Pam Tolomeo; Ebbing Lautenbach
Journal:  Am J Transplant       Date:  2019-06-26       Impact factor: 8.086

8.  Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection.

Authors:  Peter P Reese; Tara Tehrani; Mary Ann Lim; David A Asch; Emily A Blumberg; Maureen K Simon; Roy D Bloom; Scott D Halpern
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-25       Impact factor: 8.237

9.  Effect of a Mobile Web App on Kidney Transplant Candidates' Knowledge About Increased Risk Donor Kidneys: A Randomized Controlled Trial.

Authors:  Elisa J Gordon; Min-Woong Sohn; Chih-Hung Chang; Gwen McNatt; Karina Vera; Nicole Beauvais; Emily Warren; Roslyn B Mannon; Michael G Ison
Journal:  Transplantation       Date:  2017-06       Impact factor: 4.939

10.  Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.

Authors:  Mary G Bowring; Courtenay M Holscher; Sheng Zhou; Allan B Massie; Jacqueline Garonzik-Wang; Lauren M Kucirka; Sommer E Gentry; Dorry L Segev
Journal:  Am J Transplant       Date:  2017-12-05       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.